Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 197569-11-2 | MDL No. : | MFCD03695496 |
Formula : | C12H18N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | N/A |
M.W : | 222.28 g/mol | Pubchem ID : | - |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.67 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 65.48 |
TPSA : | 53.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.78 cm/s |
Log Po/w (iLOGP) : | 2.74 |
Log Po/w (XLOGP3) : | 1.24 |
Log Po/w (WLOGP) : | 2.09 |
Log Po/w (MLOGP) : | 1.23 |
Log Po/w (SILICOS-IT) : | 1.54 |
Consensus Log Po/w : | 1.77 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.8 |
Solubility : | 3.51 mg/ml ; 0.0158 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.96 |
Solubility : | 2.45 mg/ml ; 0.011 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.63 |
Solubility : | 5.23 mg/ml ; 0.0236 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.79 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280 | UN#: | N/A |
Hazard Statements: | H302-H312-H332 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 20℃; for 72h; Inert atmosphere; | 8 tert-butyl 4-(3-amino-4-(benzyloxy)-lH-pyrazolo[4,3-c]pyridin-l-yl)-4- (cyan omethyl)p ip er idine- 1 -car b oxylate To a solution of 4-(benzyloxy)-lH-pyrazolo[4,3-c]pyridin-3-amine (155 g, 645 mmol) in CH3CN (2.50 L), was added (batchwise) iert-butyl 4-(cyanomethylidene)piperidine-l- carboxylate (286 g, 1.29 mol) followed by dropwise addition of DBU (99.0 g, 650 mmol) at 20°C over 20 minutes. The resulting solution was stirred for 3 days at 20°C, concentrated in vacuo at 40-45°C, and then purified by silica chromatography, eluting with 0-50% ethyl acetate/petroleum ether. Concentration of the desired fraction in vacuo afforded compound 1-8. LRMS (ESI) calc'd for C25H3iN603 [M+H]+: 463, found 463. 1H NMR (300 MHz, CDC13): δ 7.82 (d, 1H), 7.34-7.50 (m, 5H), 6.84 (d, 1H), 5.54 (s, 2H), 4.51 (br s, 2H), 3.94-3.97 (d, 2H), 3.05 (br s, 2H), 2.85-2.90 (m, 2H), 2.79 (s, 2H), 1.92-2.04 (m, 2H), 1.45 (s, 9H). | |
With 1,8-diazabicyclo[5.4.0]undec-7-ene In acetonitrile at 20℃; Inert atmosphere; | 1 Step 1: tert-butyl 4-’(3--amino-’4--( benzyloxy)-’iiipyrazolo[4,3--c1pyridin--i--yfl--4-- (cyanomethyl )piperidine- I -carboxylate To a solution of 4-.(henzyioxy-’1iI-pyrazoio[4,3--c]pyridin-.3--amine (155 g, 645mmol) in CH3CN (2.50 L), was added (batchwise) tert-butyl 4-(cyanomethyiidene)piperidine--i--carboxylate (286 g. 1.29 mol) followed by dropwise addition of DBU (99.0 g, 650 mmol) at 20°C over 20 minutes. The resulting solution was stirred for 3 days at 20°C, concentrated in vacuo at 40---45°C, and then purified by silica chromatography, eluting with 0---50% ethyl acetate/hexanes, Concentration of the desired fraction in vacuo afforded the title compound.LRMS (ES1) caic’d for C25H31N603 [M+Hf: 463, found 463. ‘H NMR (300 MHz, CDCi3): 67.82 (ci, 1H), 734-750 (in, SF1), 6.84 (ci, 1H), 554 (s, 2H), 4.51 (hr s, 2H), 3.94-3.97 (d, 2H),3.05 (br s, 2H), 2.85-2.90 (m, 2H), 2.79 (s, 2K), 1.92-2.04 (in, 2H), 1.45 (s, 9H). |
[ 1198283-75-8 ]
tert-Butyl 4-(1-cyanopropylidene)piperidine-1-carboxylate
Similarity: 0.95
[ 1159982-27-0 ]
tert-Butyl 3-(cyanomethylene)piperidine-1-carboxylate
Similarity: 0.92
[ 1198283-75-8 ]
tert-Butyl 4-(1-cyanopropylidene)piperidine-1-carboxylate
Similarity: 0.95
[ 889955-48-0 ]
tert-Butyl 4-ethylidenepiperidine-1-carboxylate
Similarity: 0.93
[ 1159982-27-0 ]
tert-Butyl 3-(cyanomethylene)piperidine-1-carboxylate
Similarity: 0.92
[ 1198287-32-9 ]
tert-Butyl 4-butylidenepiperidine-1-carboxylate
Similarity: 0.91
[ 198892-80-7 ]
tert-Butyl 4-(2-hydroxyethylidene)piperidine-1-carboxylate
Similarity: 0.89
[ 1198283-75-8 ]
tert-Butyl 4-(1-cyanopropylidene)piperidine-1-carboxylate
Similarity: 0.95
[ 889955-48-0 ]
tert-Butyl 4-ethylidenepiperidine-1-carboxylate
Similarity: 0.93
[ 1159982-27-0 ]
tert-Butyl 3-(cyanomethylene)piperidine-1-carboxylate
Similarity: 0.92
[ 1198287-32-9 ]
tert-Butyl 4-butylidenepiperidine-1-carboxylate
Similarity: 0.91
[ 198892-80-7 ]
tert-Butyl 4-(2-hydroxyethylidene)piperidine-1-carboxylate
Similarity: 0.89
[ 1198283-75-8 ]
tert-Butyl 4-(1-cyanopropylidene)piperidine-1-carboxylate
Similarity: 0.95
[ 889955-48-0 ]
tert-Butyl 4-ethylidenepiperidine-1-carboxylate
Similarity: 0.93
[ 1159982-27-0 ]
tert-Butyl 3-(cyanomethylene)piperidine-1-carboxylate
Similarity: 0.92
[ 1198287-32-9 ]
tert-Butyl 4-butylidenepiperidine-1-carboxylate
Similarity: 0.91
[ 198892-80-7 ]
tert-Butyl 4-(2-hydroxyethylidene)piperidine-1-carboxylate
Similarity: 0.89